Cargando…
Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice
Obesity is a global epidemic affecting chronic inflammatory diseases. Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that can occur as an extraintestinal manifestation of inflammatory bowel disease (IBD). Previously we reported that patients with PSC who are obese have a...
Autores principales: | Reyes, José L., Vannan, Danielle T., Vo, Tina, Gulamhusein, Aliya, Beck, Paul L., Reimer, Raylene A., Eksteen, Bertus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814438/ https://www.ncbi.nlm.nih.gov/pubmed/29449577 http://dx.doi.org/10.1038/s41598-018-21112-7 |
Ejemplares similares
-
NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis
por: González, Marisol Ibet, et al.
Publicado: (2020) -
Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma
por: González, Marisol I., et al.
Publicado: (2022) -
Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease
por: Reyes, José L., et al.
Publicado: (2018) -
Comparison of Glucose and Satiety Hormone Response to Oral Glucose vs. Two Mixed-Nutrient Meals in Rats
por: Vannan, Danielle T., et al.
Publicado: (2018) -
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
por: Trauner, Michael, et al.
Publicado: (2019)